Ranawat Orthopaedic Res Fdn Inc New York City, NY - 10021

Ranawat Orthopaedic Res Fdn Inc is categorized under Medical Centers in New York City, NY and active since 2010.

Ranawat Orthopaedic Res Fdn Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 621112 by the NAICS.

If you are seeking more information, feel free to contact Chitranjan S Ranawat at the company’s single location by writing to 535 East 70th St Floor 6, New York City, New York NY 10021 or by phoning (646) 797-8700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Ranawat Orthopaedic Res Fdn Inc
Contact Person: Chitranjan S Ranawat
Address: 535 East 70th St Floor 6, New York City, New York 10021
Phone Number: (646) 797-8700
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Centers
SIC Code: 8011
NAICS Code: 621112
Share This Business:

Ranawat Orthopaedic Res Fdn Inc was started in 2010 to provide professional Medical Centers under the SIC code 8011 and NAICS code 621112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Chitranjan S Ranawat for inquiries that concern Ranawat Orthopaedic Res Fdn Inc by calling the company number (646) 797-8700, as your correspondence is most welcome. Additionally, the physical location of the single location of Ranawat Orthopaedic Res Fdn Inc can be found at the coordinates 40.765173,-73.95344 as well as the street address 535 East 70th St Floor 6 in New York City, New York 10021.

For its online presence, you may visit Ranawat Orthopaedic Res Fdn Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.